|
⚲
|
| Keyboard |
| Christopher de Souza | |
|---|---|
| Firm | |
| Address | 1900 2nd Avenue North Suite 300 Birmingham, AL 35203 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Fifth Asset Inc | 021-592721 | Director | 1.0 M of 1.0 M |
||
| Rarestep Inc | 021-543627 | Director | 454.0 M of 454.0 M |
||
| GILA Therapeutics Inc | 021-498961 | Director | 0.4 M of 10.0 M |
||
| Mellitus LLC | 021-491185 | Director | 0.1 M of 0.8 M |
||
| Fifth Asset Inc | 021-487946 | Director | 12.5 M of 12.5 M |
||
| GILA Therapeutics Inc | 021-466050 | Director | 0.4 M of 5.0 M |
||
| Fifth Asset Inc | 021-456525 | Director | 6.8 M of 7.5 M |
||
| Mosyle Corp | 021-444375 | Director | 162.5 M of 162.5 M |
||
| Securends Inc | 021-406649 | Director | 15.0 M of 15.0 M |
||
| GILA Therapeutics Inc | 021-389531 | Director | 1.2 M of 1.2 M |
||
| Mosyle Corp | 021-380357 | Director | 32.9 M of 32.9 M |
||
| Mellitus LLC | 021-338982 | Director | 2.8 M of 2.8 M |
||
| GILA Therapeutics Inc | 021-334701 | Director | 0.3 M of 2.0 M |
||
| Mellitus LLC | 021-322612 | Director | 1.7 M of 1.7 M |
||
| Mellitus LLC | 021-319063 | Director | 1.7 M of 1.7 M |
||
| GILA Therapeutics Inc | 021-280594 | Director | of 0.5 M |
||